These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10878638)

  • 1. Corrected QT interval prolongation associated with intravenous haloperidol in acute coronary syndromes.
    Douglas PH; Block PC
    Catheter Cardiovasc Interv; 2000 Jul; 50(3):352-5. PubMed ID: 10878638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between intravenous haloperidol and prolonged QT interval.
    Hatta K; Takahashi T; Nakamura H; Yamashiro H; Asukai N; Matsuzaki I; Yonezawa Y
    J Clin Psychopharmacol; 2001 Jun; 21(3):257-61. PubMed ID: 11386487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective study of the safety of intramuscular ziprasidone in agitated elderly patients.
    Greco KE; Tune LE; Brown FW; Van Horn WA
    J Clin Psychiatry; 2005 Jul; 66(7):928-9. PubMed ID: 16013910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A computerized physician order entry set designed to improve safety of intravenous haloperidol utilization: a retrospective study in agitated hospitalized patients.
    Muzyk AJ; Rivelli SK; Jiang W; Heinz H; Rayfield A; Gagliardi JP
    Drug Saf; 2012 Sep; 35(9):725-31. PubMed ID: 22876752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of intravenous administration of the antipsychotic drug benperidol on the QT interval.
    Schmidt A; Fischer P; Wally B; Scharfetter J
    Neuropsychiatr; 2017 Dec; 31(4):172-175. PubMed ID: 28791627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill.
    Metzger E; Friedman R
    J Clin Psychopharmacol; 1993 Apr; 13(2):128-32. PubMed ID: 8463445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Torsades de pointes secondary to intravenous haloperidol after coronary bypass grafting surgery.
    Perrault LP; Denault AY; Carrier M; Cartier R; Bélisle S
    Can J Anaesth; 2000 Mar; 47(3):251-4. PubMed ID: 10730737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of corrected QT-interval prolongation in patients with unstable angina pectoris.
    Gadaleta FL; Llois SC; Lapuente AR; Batchvarov VN; Kaski JC
    Am J Cardiol; 2003 Jul; 92(2):203-5. PubMed ID: 12860225
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of haloperidol infusions to control delirium in critically ill adults.
    Seneff MG; Mathews RA
    Ann Pharmacother; 1995; 29(7-8):690-3. PubMed ID: 8520081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of cardiac arrhythmias in acute coronary syndromes.
    Nguyen N; Reddy PC
    J La State Med Soc; 2001 Jun; 153(6):300-5. PubMed ID: 11480380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of uncorrected versus corrected QT interval for prediction of torsade de pointes associated with intravenous haloperidol.
    Tisdale JE; Kovacs R; Mi D; McCabe GP; Cariera BL; Sharma N; Rosman H
    Pharmacotherapy; 2007 Feb; 27(2):175-82. PubMed ID: 17253907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haloperidol-induced torsade de pointes.
    O'Brien JM; Rockwood RP; Suh KI
    Ann Pharmacother; 1999 Oct; 33(10):1046-50. PubMed ID: 10534216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Arrhythmia in acute coronary syndrome].
    Goldner V
    Acta Med Croatica; 2004; 58(2):163-5. PubMed ID: 15208805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced Brugada syndrome with ST-T wave alternans and long QT.
    Roberts-Thomson KC; Teo KS; Young GD
    Intern Med J; 2007 Mar; 37(3):199-200. PubMed ID: 17316344
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: comparison with QT interval prolongation for assessment of risk of Torsades de Pointes.
    Tisdale JE; Rasty S; Padhi ID; Sharma ND; Rosman H
    J Clin Pharmacol; 2001 Dec; 41(12):1310-8. PubMed ID: 11762558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill: a review of the literature.
    Lawrence KR; Nasraway SA
    Pharmacotherapy; 1997; 17(3):531-7. PubMed ID: 9165555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome and cardiac surgery. A case report.
    Sirois F
    J Cardiovasc Surg (Torino); 2008 Oct; 49(5):695-6. PubMed ID: 18670390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing ICU Subsyndromal Delirium Conversion to Delirium With Low-Dose IV Haloperidol: A Double-Blind, Placebo-Controlled Pilot Study.
    Al-Qadheeb NS; Skrobik Y; Schumaker G; Pacheco MN; Roberts RJ; Ruthazer RR; Devlin JW
    Crit Care Med; 2016 Mar; 44(3):583-91. PubMed ID: 26540397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haloperidol Versus 5-HT
    Singh PM; Borle A; Makkar JK; Trikha A; Fish D; Sinha A
    J Clin Pharmacol; 2018 Feb; 58(2):131-143. PubMed ID: 28914976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis.
    Czekalla J; Beasley CM; Dellva MA; Berg PH; Grundy S
    J Clin Psychiatry; 2001 Mar; 62(3):191-8. PubMed ID: 11305706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.